HIMS vs RARE · P/E 74, rev $1.36B vs rev $350.0M
Hims Hers Health Inc (HIMS) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Hims Hers Health Inc (HIMS) is a household & personal products company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported HIMS revenue for 2026-06-30 was $1.36B. Net income was -$178.4M. HIMS currently screens at market cap $11.04B and trailing P/E 73.9.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
HIMS currently screens at market cap $11.04B and trailing P/E 73.9. RARE currently screens at market cap $2.79B.
Not investment advice. Open the HIMS and RARE stock pages for the full models.
Not investment advice.